Behavioural Management in Alzheimer's Disease - Pharmacology

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  2010-12-08

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/9780470669600.CH53
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The economic impact of neuropsychiatric symptoms in Alzheimer’s disease

  2012cited by this paper
• The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.

  2009cited by this paper
• Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study.

  2009cited by this paper
• ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia

  2008cited by this paper
• A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease.

  2008cited by this paper
• Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6‐week, double‐blind, placebo‐controlled study

  2008cited by this paper
• Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.

  2008cited by this paper
• Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo‐controlled study––The Bergen District Nursing Home Study (BEDNURS)

  2008cited by this paper
• Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.

  2007cited by this paper
• Quetiapine for agitation or psychosis in patients with dementia and parkinsonism

  2007cited by this paper
• A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia.

  2007cited by this paper
• Donepezil for the treatment of agitation in Alzheimer's disease.

  2007cited by this paper
• The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta‐analysis of 4 placebo‐controlled clinical trials

  2007cited by this paper
• Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study.

  2007cited by this paper
• Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

  2006cited by this paper
• Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.

  2006cited by this paper
• Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial.

  2006cited by this paper
• Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment

  2006cited by this paper
• Caregivers' reasons for nursing home placement: clues for improving discussions with families prior to the transition.

  2006cited by this paper
• Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

  2006cited by this paper
• A Placebo-Controlled Trial of Valproate for Agitation and Aggression in Alzheimer’s Disease

  2006cited by this paper
• Regular Research ArticlesA Cross-Sectional Study of Neuropsychiatric Symptoms in 435 Patients With Alzheimer's Disease

  2005cited by this paper
• Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003.

  2005cited by this paper
• Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study

  2005cited by this paper
• Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

  2005cited by this paper
• Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

  2005cited by this paper
• Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia.

  2005cited by this paper
• Propranolol for Disruptive Behaviors in Nursing Home Residents With Probable or Possible Alzheimer Disease: A Placebo-Controlled Study

  2005cited by this paper
• Aripiprazole for the Treatment of Psychosis in Patients With Alzheimer's Disease: A Randomized, Placebo-Controlled Study

  2005cited by this paper
• Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial.

  2005cited by this paper
• Risk of death in elderly users of conventional vs. atypical antipsychotic medications.

  2005cited by this paper
• A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease.

  2005cited by this paper
• Transdermal estrogen patches for aggressive behavior in male patients with dementia: a randomized, controlled trial

  2005cited by this paper
• A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Safety and Tolerability of Two Doses of Divalproex Sodium in Outpatients with Probable Alzheimers Disease

  2005cited by this paper
• Regression to the mean: implications for clinical trials of psychotropic agents in dementia.

  2004cited by this paper
• Frontotemporal Dementia: A Randomised, Controlled Trial with Trazodone

  2004cited by this paper
• Atypical antipsychotics and risk of cerebrovascular accidents.

  2004cited by this paper
• A randomized, placebo‐controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil

  2004cited by this paper
• Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease

  2004cited by this paper
• Delusions and hallucinations in Alzheimer's disease: review of the brain decade.

  2003cited by this paper
• Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis.

  2003cited by this paper
• A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.

  2003cited by this paper
• Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial.

  2003cited by this paper
• Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease.

  2003cited by this paper
• Haloperidol for agitation in dementia.

  2002cited by this paper
• Comparison of Rapidly Acting Intramuscular Olanzapine, Lorazepam, and Placebo: A Double-blind, Randomized Study in Acutely Agitated Patients with Dementia

  2002cited by this paper
• Sodium valproate in the treatment of aggressive behavior in patients with dementia—a randomized placebo controlled clinical trial

  2002cited by this paper
• The incremental direct costs associated with behavioral symptoms in AD

  2002cited by this paper
• Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease

  2002cited by this paper
• Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients.

  2002cited by this paper
• A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer disease.

  2001cited by this paper
• A Randomized, Double‐Blind, Placebo‐Controlled Study of the Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease in the Nursing Home Setting

  2001cited by this paper
• Placebo-controlled study of divalproex sodium for agitation in dementia.

  2001cited by this paper
• Fluvoxamine for psychosis in Alzheimer's disease.

  2001cited by this paper
• Does Behavioral Improvement with Haloperidol or Trazodone Treatment Depend on Psychosis or Mood Symptoms in Patients with Dementia?

  2001cited by this paper
• Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging.

  2000cited by this paper
• Treatment of agitation in AD

  2000cited by this paper
• Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group.

  2000cited by this paper
• Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome.

  2000cited by this paper
• A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia

  1999cited by this paper
• Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.

  1999cited by this paper
• Alprazolam as an Alternative to Low‐Dose Haloperidol in Older, Cognitively Impaired Nursing Facility Patients

  1998cited by this paper
• Efficacy and tolerability of carbamazepine for agitation and aggression in dementia.

  1998cited by this paper
• A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia.

  1997cited by this paper
• The Evolution of Psychiatric Symptoms in Alzheimer's Disease: A Natural History Study

  1996cited by this paper
• Buspirone vs. Haloperidol: A Double-Blind Trial for Agitation in a Nursing Home Population With Alzheimer's Disease.

  1996cited by this paper
• The Neurobehavioral Rating Scale: reliability in patients with dementia.

  1995cited by this paper
• Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes.

  1995cited by this paper
• The Neuropsychiatric Inventory

  1994cited by this paper
• Behavioral Syndromes in Alzheimer's Disease

  1992cited by this paper
• Fluvoxamine in the treatment of demented elderly patients: a double‐blind, placebo‐controlled study

  1992cited by this paper
• Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients.

  1990cited by this paper
• A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia

  1990cited by this paper
• A description of agitation in a nursing home.

  1989cited by this paper
• The Nature of Psychotic Symptoms in Senile Dementia of the Alzheimer Type

  1988cited by this paper
• Clinician-rated scales for multidimensional assessment of psychopathology in the elderly.

  1988cited by this paper

• Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024

  2025cites this paper
• ASSOCIATION BETWEENTHESYMPTOMS OF BEHAVIOR CHANGES IN PEOPLE WITH DEMENTIA (ODD) AND STRESS LEVELS IN CAREGIVERS

  2024cites this paper